カテゴリー： Market Monitor Global, 世界, 医療/バイオ

痔疾患治療の世界市場見通し2023年-2029年

◆英語タイトル：Hemorrhoids Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU4922）◆商品コード：MMG23JU4922
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：62
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Hemorrhoids Treatment Market 調査レポートは次の情報を含め、グローバルにおけるの痔疾患治療市場規模と予測を収録しています。・世界の痔疾患治療市場：売上、2018年-2023年、2024年-2029年
・世界の痔疾患治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の痔疾患治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「バンド結紮器」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

痔疾患治療のグローバル主要企業は、Abbott Laboratories、 AstraZeneca plc、 Bayer AG、 Boehringer Ingelheim GmbH、 Boston Scientific Corporation、 CONMED Corporation、 Cook Medical、 GlaxoSmithKline、 Olympus Corporation、 Pfizer Inc.、 Johnson & Johnson Services, Inc、 F. Hoffmann-La Roche Ltd、 Novartis AG、 Teva Pharmaceutical Industries Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、痔疾患治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の痔疾患治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の痔疾患治療市場：タイプ別市場シェア、2022年
・バンド結紮器、硬化療法用注射器、赤外線凝固装置、バイポーラプローブ、凍結療法装置、痔核レーザープローブ、その他

世界の痔疾患治療市場：用途別、2018年-2023年、2024年-2029年
世界の痔疾患治療市場：用途別市場シェア、2022年
・病院・クリニック、在宅医療、その他

世界の痔疾患治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の痔疾患治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における痔疾患治療のグローバル売上、2018年-2023年
・主要企業における痔疾患治療のグローバル売上シェア、2022年
・主要企業における痔疾患治療のグローバル販売量、2018年-2023年
・主要企業における痔疾患治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Abbott Laboratories、 AstraZeneca plc、 Bayer AG、 Boehringer Ingelheim GmbH、 Boston Scientific Corporation、 CONMED Corporation、 Cook Medical、 GlaxoSmithKline、 Olympus Corporation、 Pfizer Inc.、 Johnson & Johnson Services, Inc、 F. Hoffmann-La Roche Ltd、 Novartis AG、 Teva Pharmaceutical Industries Ltd.

*************************************************************

・調査・分析レポートの概要
痔疾患治療市場の定義
市場セグメント
世界の痔疾患治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の痔疾患治療市場規模
世界の痔疾患治療市場規模：2022年 VS 2029年
世界の痔疾患治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの痔疾患治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の痔疾患治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：バンド結紮器、硬化療法用注射器、赤外線凝固装置、バイポーラプローブ、凍結療法装置、痔核レーザープローブ、その他
痔疾患治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院・クリニック、在宅医療、その他
痔疾患治療の用途別グローバル売上・予測

・地域別市場分析
地域別痔疾患治療市場規模 2022年と2029年
地域別痔疾患治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbott Laboratories、 AstraZeneca plc、 Bayer AG、 Boehringer Ingelheim GmbH、 Boston Scientific Corporation、 CONMED Corporation、 Cook Medical、 GlaxoSmithKline、 Olympus Corporation、 Pfizer Inc.、 Johnson & Johnson Services, Inc、 F. Hoffmann-La Roche Ltd、 Novartis AG、 Teva Pharmaceutical Industries Ltd.
...

This report aims to provide a comprehensive presentation of the global market for Hemorrhoids Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemorrhoids Treatment. This report contains market size and forecasts of Hemorrhoids Treatment in global, including the following market information:
Global Hemorrhoids Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hemorrhoids Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Band Ligator Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hemorrhoids Treatment include Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Boston Scientific Corporation, CONMED Corporation, Cook Medical, GlaxoSmithKline and Olympus Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemorrhoids Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemorrhoids Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hemorrhoids Treatment Market Segment Percentages, by Type, 2022 (%)
Band Ligator
Sclerotherapy Injector
Infrared Coagulator
Bipolar Probe
Cryotherapy Device
Hemorrhoid Laser Probes
Others
Global Hemorrhoids Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hemorrhoids Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital and Clinics
Homecare
Others
Global Hemorrhoids Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hemorrhoids Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemorrhoids Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hemorrhoids Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
AstraZeneca plc
Bayer AG
Boehringer Ingelheim GmbH
Boston Scientific Corporation
CONMED Corporation
Cook Medical
GlaxoSmithKline
Olympus Corporation
Pfizer Inc.
Johnson & Johnson Services, Inc
F. Hoffmann-La Roche Ltd
Novartis AG
Teva Pharmaceutical Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemorrhoids Treatment, market overview.
Chapter 2: Global Hemorrhoids Treatment market size in revenue.
Chapter 3: Detailed analysis of Hemorrhoids Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemorrhoids Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Hemorrhoids Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemorrhoids Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemorrhoids Treatment Overall Market Size
2.1 Global Hemorrhoids Treatment Market Size: 2022 VS 2029
2.2 Global Hemorrhoids Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hemorrhoids Treatment Players in Global Market
3.2 Top Global Hemorrhoids Treatment Companies Ranked by Revenue
3.3 Global Hemorrhoids Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hemorrhoids Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hemorrhoids Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemorrhoids Treatment Players in Global Market
3.6.1 List of Global Tier 1 Hemorrhoids Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Hemorrhoids Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Hemorrhoids Treatment Market Size Markets, 2022 & 2029
4.1.2 Band Ligator
4.1.3 Sclerotherapy Injector
4.1.4 Infrared Coagulator
4.1.5 Bipolar Probe
4.1.6 Cryotherapy Device
4.1.7 Hemorrhoid Laser Probes
4.1.8 Others
4.2 By Type – Global Hemorrhoids Treatment Revenue & Forecasts
4.2.1 By Type – Global Hemorrhoids Treatment Revenue, 2018-2023
4.2.2 By Type – Global Hemorrhoids Treatment Revenue, 2024-2029
4.2.3 By Type – Global Hemorrhoids Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hemorrhoids Treatment Market Size, 2022 & 2029
5.1.2 Hospital and Clinics
5.1.3 Homecare
5.1.4 Others
5.2 By Application – Global Hemorrhoids Treatment Revenue & Forecasts
5.2.1 By Application – Global Hemorrhoids Treatment Revenue, 2018-2023
5.2.2 By Application – Global Hemorrhoids Treatment Revenue, 2024-2029
5.2.3 By Application – Global Hemorrhoids Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Hemorrhoids Treatment Market Size, 2022 & 2029
6.2 By Region – Global Hemorrhoids Treatment Revenue & Forecasts
6.2.1 By Region – Global Hemorrhoids Treatment Revenue, 2018-2023
6.2.2 By Region – Global Hemorrhoids Treatment Revenue, 2024-2029
6.2.3 By Region – Global Hemorrhoids Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Hemorrhoids Treatment Revenue, 2018-2029
6.3.2 US Hemorrhoids Treatment Market Size, 2018-2029
6.3.3 Canada Hemorrhoids Treatment Market Size, 2018-2029
6.3.4 Mexico Hemorrhoids Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Hemorrhoids Treatment Revenue, 2018-2029
6.4.2 Germany Hemorrhoids Treatment Market Size, 2018-2029
6.4.3 France Hemorrhoids Treatment Market Size, 2018-2029
6.4.4 U.K. Hemorrhoids Treatment Market Size, 2018-2029
6.4.5 Italy Hemorrhoids Treatment Market Size, 2018-2029
6.4.6 Russia Hemorrhoids Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Hemorrhoids Treatment Market Size, 2018-2029
6.4.8 Benelux Hemorrhoids Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Hemorrhoids Treatment Revenue, 2018-2029
6.5.2 China Hemorrhoids Treatment Market Size, 2018-2029
6.5.3 Japan Hemorrhoids Treatment Market Size, 2018-2029
6.5.4 South Korea Hemorrhoids Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Hemorrhoids Treatment Market Size, 2018-2029
6.5.6 India Hemorrhoids Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Hemorrhoids Treatment Revenue, 2018-2029
6.6.2 Brazil Hemorrhoids Treatment Market Size, 2018-2029
6.6.3 Argentina Hemorrhoids Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Hemorrhoids Treatment Revenue, 2018-2029
6.7.2 Turkey Hemorrhoids Treatment Market Size, 2018-2029
6.7.3 Israel Hemorrhoids Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Hemorrhoids Treatment Market Size, 2018-2029
6.7.5 UAE Hemorrhoids Treatment Market Size, 2018-2029
7 Hemorrhoids Treatment Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Hemorrhoids Treatment Major Product Offerings
7.1.4 Abbott Laboratories Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 AstraZeneca plc
7.2.1 AstraZeneca plc Company Summary
7.2.2 AstraZeneca plc Business Overview
7.2.3 AstraZeneca plc Hemorrhoids Treatment Major Product Offerings
7.2.4 AstraZeneca plc Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca plc Key News & Latest Developments
7.3 Bayer AG
7.3.1 Bayer AG Company Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Hemorrhoids Treatment Major Product Offerings
7.3.4 Bayer AG Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.3.5 Bayer AG Key News & Latest Developments
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Company Summary
7.4.2 Boehringer Ingelheim GmbH Business Overview
7.4.3 Boehringer Ingelheim GmbH Hemorrhoids Treatment Major Product Offerings
7.4.4 Boehringer Ingelheim GmbH Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.4.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Company Summary
7.5.2 Boston Scientific Corporation Business Overview
7.5.3 Boston Scientific Corporation Hemorrhoids Treatment Major Product Offerings
7.5.4 Boston Scientific Corporation Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.5.5 Boston Scientific Corporation Key News & Latest Developments
7.6 CONMED Corporation
7.6.1 CONMED Corporation Company Summary
7.6.2 CONMED Corporation Business Overview
7.6.3 CONMED Corporation Hemorrhoids Treatment Major Product Offerings
7.6.4 CONMED Corporation Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.6.5 CONMED Corporation Key News & Latest Developments
7.7 Cook Medical
7.7.1 Cook Medical Company Summary
7.7.2 Cook Medical Business Overview
7.7.3 Cook Medical Hemorrhoids Treatment Major Product Offerings
7.7.4 Cook Medical Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.7.5 Cook Medical Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Hemorrhoids Treatment Major Product Offerings
7.8.4 GlaxoSmithKline Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Olympus Corporation
7.9.1 Olympus Corporation Company Summary
7.9.2 Olympus Corporation Business Overview
7.9.3 Olympus Corporation Hemorrhoids Treatment Major Product Offerings
7.9.4 Olympus Corporation Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.9.5 Olympus Corporation Key News & Latest Developments
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Company Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Hemorrhoids Treatment Major Product Offerings
7.10.4 Pfizer Inc. Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.10.5 Pfizer Inc. Key News & Latest Developments
7.11 Johnson & Johnson Services, Inc
7.11.1 Johnson & Johnson Services, Inc Company Summary
7.11.2 Johnson & Johnson Services, Inc Business Overview
7.11.3 Johnson & Johnson Services, Inc Hemorrhoids Treatment Major Product Offerings
7.11.4 Johnson & Johnson Services, Inc Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.11.5 Johnson & Johnson Services, Inc Key News & Latest Developments
7.12 F. Hoffmann-La Roche Ltd
7.12.1 F. Hoffmann-La Roche Ltd Company Summary
7.12.2 F. Hoffmann-La Roche Ltd Business Overview
7.12.3 F. Hoffmann-La Roche Ltd Hemorrhoids Treatment Major Product Offerings
7.12.4 F. Hoffmann-La Roche Ltd Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.12.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.13 Novartis AG
7.13.1 Novartis AG Company Summary
7.13.2 Novartis AG Business Overview
7.13.3 Novartis AG Hemorrhoids Treatment Major Product Offerings
7.13.4 Novartis AG Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.13.5 Novartis AG Key News & Latest Developments
7.14 Teva Pharmaceutical Industries Ltd.
7.14.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.14.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.14.3 Teva Pharmaceutical Industries Ltd. Hemorrhoids Treatment Major Product Offerings
7.14.4 Teva Pharmaceutical Industries Ltd. Hemorrhoids Treatment Revenue in Global Market (2018-2023)
7.14.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Hemorrhoids Treatment Market Opportunities & Trends in Global Market
Table 2. Hemorrhoids Treatment Market Drivers in Global Market
Table 3. Hemorrhoids Treatment Market Restraints in Global Market
Table 4. Key Players of Hemorrhoids Treatment in Global Market
Table 5. Top Hemorrhoids Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hemorrhoids Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hemorrhoids Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hemorrhoids Treatment Product Type
Table 9. List of Global Tier 1 Hemorrhoids Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemorrhoids Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Hemorrhoids Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Hemorrhoids Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hemorrhoids Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Hemorrhoids Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Hemorrhoids Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hemorrhoids Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Hemorrhoids Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Hemorrhoids Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hemorrhoids Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hemorrhoids Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hemorrhoids Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hemorrhoids Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hemorrhoids Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hemorrhoids Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Hemorrhoids Treatment Product Offerings
Table 32. Abbott Laboratories Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. AstraZeneca plc Company Summary
Table 35. AstraZeneca plc Hemorrhoids Treatment Product Offerings
Table 36. AstraZeneca plc Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca plc Key News & Latest Developments
Table 38. Bayer AG Company Summary
Table 39. Bayer AG Hemorrhoids Treatment Product Offerings
Table 40. Bayer AG Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Bayer AG Key News & Latest Developments
Table 42. Boehringer Ingelheim GmbH Company Summary
Table 43. Boehringer Ingelheim GmbH Hemorrhoids Treatment Product Offerings
Table 44. Boehringer Ingelheim GmbH Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 46. Boston Scientific Corporation Company Summary
Table 47. Boston Scientific Corporation Hemorrhoids Treatment Product Offerings
Table 48. Boston Scientific Corporation Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Boston Scientific Corporation Key News & Latest Developments
Table 50. CONMED Corporation Company Summary
Table 51. CONMED Corporation Hemorrhoids Treatment Product Offerings
Table 52. CONMED Corporation Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. CONMED Corporation Key News & Latest Developments
Table 54. Cook Medical Company Summary
Table 55. Cook Medical Hemorrhoids Treatment Product Offerings
Table 56. Cook Medical Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Cook Medical Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Hemorrhoids Treatment Product Offerings
Table 60. GlaxoSmithKline Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Olympus Corporation Company Summary
Table 63. Olympus Corporation Hemorrhoids Treatment Product Offerings
Table 64. Olympus Corporation Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Olympus Corporation Key News & Latest Developments
Table 66. Pfizer Inc. Company Summary
Table 67. Pfizer Inc. Hemorrhoids Treatment Product Offerings
Table 68. Pfizer Inc. Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Inc. Key News & Latest Developments
Table 70. Johnson & Johnson Services, Inc Company Summary
Table 71. Johnson & Johnson Services, Inc Hemorrhoids Treatment Product Offerings
Table 72. Johnson & Johnson Services, Inc Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 73. Johnson & Johnson Services, Inc Key News & Latest Developments
Table 74. F. Hoffmann-La Roche Ltd Company Summary
Table 75. F. Hoffmann-La Roche Ltd Hemorrhoids Treatment Product Offerings
Table 76. F. Hoffmann-La Roche Ltd Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 77. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 78. Novartis AG Company Summary
Table 79. Novartis AG Hemorrhoids Treatment Product Offerings
Table 80. Novartis AG Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 81. Novartis AG Key News & Latest Developments
Table 82. Teva Pharmaceutical Industries Ltd. Company Summary
Table 83. Teva Pharmaceutical Industries Ltd. Hemorrhoids Treatment Product Offerings
Table 84. Teva Pharmaceutical Industries Ltd. Hemorrhoids Treatment Revenue (US$, Mn) & (2018-2023)
Table 85. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
List of Figures
Figure 1. Hemorrhoids Treatment Segment by Type in 2022
Figure 2. Hemorrhoids Treatment Segment by Application in 2022
Figure 3. Global Hemorrhoids Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hemorrhoids Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hemorrhoids Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemorrhoids Treatment Revenue in 2022
Figure 8. By Type - Global Hemorrhoids Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Hemorrhoids Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Hemorrhoids Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Hemorrhoids Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Hemorrhoids Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Hemorrhoids Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Hemorrhoids Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Hemorrhoids Treatment Revenue Market Share, 2018-2029
Figure 16. US Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Hemorrhoids Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Hemorrhoids Treatment Revenue Market Share, 2018-2029
Figure 28. China Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Hemorrhoids Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Hemorrhoids Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Hemorrhoids Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca plc Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bayer AG Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Boehringer Ingelheim GmbH Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Boston Scientific Corporation Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. CONMED Corporation Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cook Medical Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GlaxoSmithKline Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Olympus Corporation Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Inc. Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Johnson & Johnson Services, Inc Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. F. Hoffmann-La Roche Ltd Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Novartis AG Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Teva Pharmaceutical Industries Ltd. Hemorrhoids Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 痔疾患治療の世界市場見通し2023年-2029年(Hemorrhoids Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 痔診断＆治療の世界市場見通し2023年-2029年
  • サラセミア治療の世界市場見通し2023年-2029年
  • CLI＆PAD治療の世界市場見通し2023年-2029年
  • 肺動脈高血圧症治療の世界市場見通し2023年-2029年
  • 皮膚糸状菌症治療の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆